Open AccessAntiplatelet therapy in coronary artery disease after surgical revascularization
Author(s) -
А. В. Панов,
М Л Гордеев,
Vikentiy Y. Kozulin,
K. V. Korzhenevskaya,
N. A. Tyan
Publication year - 2009
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2009-15-3-256-261
Subject(s) - medicine , clopidogrel , perioperative , coronary artery disease , revascularization , cardiology , randomized controlled trial , artery , coronary artery bypass surgery , aspirin , surgery , myocardial infarction
The article summarizes the data on antiplatelet therapy in patients with coronary artery disease (CAD) undergoing coronary artery bypass graft surgery. The results of both randomized and open efficiency and safety trials of acetylsalicylic acid (ASA) and clopidogrel in the perioperative period are discussed as well as our own study results on association of ASA postoperative therapy with CAD recurrence after surgical revascularization are presented.